Subsidiary19 Oct 2026, 07:30 pm
Alembic Pharma Incorporates UAE Subsidiary
AI Summary
Alembic Pharmaceuticals Ltd announced the incorporation of its wholly-owned subsidiary, Alvesta Pharmaceuticals FZCO, in Dubai, United Arab Emirates, on September 1, 2026. This new entity, a step-down subsidiary of Alembic Pharmaceuticals, was established with a cash consideration of AED 100,000. Alvesta Pharmaceuticals FZCO will focus on exploring new business opportunities and promoting, selling, and distributing pharmaceutical products of the parent company. The incorporation signifies Alembic's strategic move to expand its international presence and business operations within the pharmaceutical sector.
Key Highlights
- Alembic Pharmaceuticals incorporated a new subsidiary in Dubai, UAE.
- The subsidiary, Alvesta Pharmaceuticals FZCO, is wholly owned.
- The new entity aims to explore new business and distribute products.
- Initial investment is AED 100,000 in cash.
Price Impact
More from APLLTD